The vaccine contract manufacturing market is estimated to grow at a CAGR of 17.4%, predicts Roots Analysis
The steadily growing demand for vaccines, fueled by the COVID-19 pandemic, coupled to the discovery and development of a variety of preventive and therapeutic vaccine products, has presented lucrative opportunities for contract manufacturers
Roots Analysis is pleased to announce the publication of its recent study, titled, “Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030.”
The report features an extensive study on contract service providers engaged in the development and manufacturing of vaccines. The study features in-depth analyses, highlighting the capabilities of various vaccine CMOs. Amongst other elements, the report includes:
- A detailed review of the overall landscape of the vaccine contract manufacturing market.
- A detailed review of the contract manufacturing landscape for COVID-19 vaccines.
- A region-wise company competitiveness analysis, highlighting the most prominent vaccine contract manufacturers.
- Elaborate profiles of the key players based in North America, Europe, and Asia-Pacific having a diverse range of capabilities for development, vaccine manufacturing and packaging of vaccines.
- An analysis of the collaborations that have been established since 2013.
- A detailed analysis of the expansions undertaken (since 2013) by various vaccine production service providers for enhancing their service portfolios.
- A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired during the time period between 2013-2021, along with the geographical distribution of this activity.
- A detailed capacity analysis, taking into consideration the manufacturing capacities of various stakeholders (small, mid-sized, large / very large vaccine CMOs) in the market.
- An informed estimate of the annual commercial and clinical demand for vaccines (in million liters).
- A discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, which are likely to impact the industry’s evolution.
- A discussion on the potential market drivers.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Scale of Operation
- Preclinical
- Clinical
- Commercial
- Type of Expression System
- Mammalian
- Microbial
- Others
- Outsourced Business Operations
- API Manufacturing
- Fill / Finish
- Others
- Company Size
- Small
- Mid-sized
- Large / Very Large
- Key geographical regions
- North America
- Europe
- Asia-Pacific
- Rest of the World
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/vaccine-contract-manufacturing-market/262.html
Other Recent Offerings
- mRNA Synthesis and Manufacturing Services Market, 2021-2030
- Biopharmaceutical CROs Market, 2021-2030
- Cold Chain Logistics Market for Vaccines, 2021 –2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Facebook – https://www.facebook.com/RootsAnalysis
LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter – https://twitter.com/RootsAnalysis
Medium – https://medium.com/@RootsAnalysis
Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/
Quora – https://rootsanalysisinsights.quora.com/
